Endoscopic ultrasound-directed transgastric ERCP (EDGE): a systematic review describing the outcomes, adverse events, and knowledge gaps
- PMID: 33506456
- PMCID: PMC8783372
- DOI: 10.1055/a-1376-2394
Endoscopic ultrasound-directed transgastric ERCP (EDGE): a systematic review describing the outcomes, adverse events, and knowledge gaps
Abstract
BACKGROUND : Endoscopic ultrasound-directed transgastric endoscopic retrograde cholangiopancreatography (EDGE) has emerged as a viable completely endoscopic method for performing pancreaticobiliary interventions in patients with Roux-en-Y gastric bypass anatomy. The aims of this systematic review were: (1) to describe the indications, outcomes, and complications of EDGE; and (2) to identify deficiencies in our knowledge of important technical approaches and clinical outcomes. METHODS : A systematic review was conducted via comprehensive searches of Medline, Scopus, CINAHL, and Cochrane to identify studies focusing on EDGE outcomes. Simple descriptive statistics were derived from case series only. Case reports were only included to qualitatively describe additional indications, techniques, and adverse events. RESULTS : The initial search identified 2143 abstracts. Nine case series and eight case reports were included. In the nine case series, 169 patients underwent EDGE. The technical success rate was 99 % (168 /169) for gastrogastrostomy/jejunogastrostomy creation and 98 % (166 /169) for subsequent ERCP. Minor adverse events specifically related to EDGE occurred in 18 % (31/169) and included intraprocedural stent migration/malposition (n = 27) and abdominal pain (n = 4). Moderate adverse events specific to EDGE occurred in 5 % (9/169): including bleeding (2 %), persistent fistula (1 %), and perforation (1 %). Severe adverse events occurred in one patient with a perforation requiring surgery. Deficiency in reporting on the clinical significance of adverse events was identified. CONCLUSION : Based on limited observational data, in expert hands, EDGE has a high rate of technical success and an acceptable rate of adverse events. As a novel procedure, many knowledge gaps need to be addressed to inform the design of meaningful comparative studies and guide informed consent.
Thieme. All rights reserved.
Conflict of interest statement
B.J. Elmunzer is a consultant for Takeda Pharmaceuticals. E.M. Forster receives research support from BMS, Janssen, and Takeda, and is a consultant for AbbVie. G.A. Cote receives research support from Kangen Pharmaceuticals and Boston Scientific Corporation; he is a consultant for Boston Scientific Corporation, Olympus Corporation of the Americas, and Abbvie. The remaining authors declare that they have no conflict of interest.
Figures


Comment in
-
Seven years later: do we still have an EDGE?Endoscopy. 2022 Jan;54(1):62-63. doi: 10.1055/a-1453-0606. Epub 2021 Aug 5. Endoscopy. 2022. PMID: 34352908 No abstract available.
References
-
- Forster E, Elmunzer BJ. Endoscopic retrograde cholangiopancreatography in patients with Roux-en-Y gastric bypass. Am J Gastroenterol 2020; 115: 155–157 - PubMed
-
- Wang TJ, Ryou M. Evolving techniques for endoscopic retrograde cholangiopancreatography in gastric bypass patients. Curr Opin Gastroenterol 2018; 34: 444–450 - PubMed
-
- Ngamruengphong S, Nieto J, Kunda R et al.. Endoscopic ultrasound-guided creation of a transgastric fistula for the management of hepatobiliary disease in patients with Roux-en-Y gastric bypass. Endoscopy 2017; 49: 549–552 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials